142
Views
20
CrossRef citations to date
0
Altmetric
Original Research

Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity

, , , &
Pages 1477-1486 | Published online: 29 Jul 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Maria Rosaria Vulpi, Vito Liotino, Silvano Dragonieri, Enrico Buonamico, Michela Dimitri, Alberto Capozzolo, Emanuela Resta, Madia Lozupone, Francesco Panza & Onofrio Resta. (2020) The association of patient-reported symptoms and clinical and lung function parameters in patients with chronic obstructive pulmonary disease in stable phase. Expert Review of Respiratory Medicine 14:6, pages 637-643.
Read now
Nurdan Kokturk, Wael Abuharbid, Amr S Albanna, Hakan Gunen, Alev Gurgun, Mousa Khadadah, Elmas Malvolti, Medhat Soliman, Richard van Zyl-Smit, Noureddine Zidouni & Ashraf Alzaabi. (2019) A Cross-Sectional Study in Patients with Severe COPD to Assess the Perception of Symptom Variability (COPVAR) in the Middle East and Africa. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2959-2970.
Read now
Joanna Rosińczuk, Maria Przyszlak & Izabella Uchmanowicz. (2018) Sociodemographic and clinical factors affecting the quality of life of patients with chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2869-2882.
Read now
Marcos Hernández, Gabriel García, Jimena Falco, Agustín R García, Vanina Martín, Manuel Ibarrola & Silvia Quadrelli. (2018) Impact of using the new GOLD classification on the distribution of COPD severity in clinical practice. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 351-356.
Read now

Articles from other publishers (16)

Cheryl L. Sershen, Taha Salim & Elebeoba E. May. (2023) Investigating the comorbidity of COPD and tuberculosis, a computational study. Frontiers in Systems Biology 3.
Crossref
Anuj Kumar Pandey, Ajay Kumar Verma, Arpita Singh, Surya Kant, Rakesh Kumar Dixit, Shyam Chand Chaudhary, Jyoti Bajpai, Ved Prakash & Umesh Pratap Verma. (2022) The Relationship Between Clinical Phenotypes and Global Initiative for Chronic Obstructive Lung Disease (GOLD) Stages/Groups in Patients With Chronic Obstructive Pulmonary Disease. Cureus.
Crossref
Kimberly L. Sterling, Jean-Louis Pépin, Walter Linde-ZwirbleJiaming Chen, Adam V. BenjafieldPeter A. Cistulli, Kate V. Cole, Hussein EmamiCaleb Woodford, Jeff P. Armitstead, Carlos M. NunezJadwiga A. Wedzicha & Atul Malhotra. (2022) Impact of Positive Airway Pressure Therapy Adherence on Outcomes in Patients with Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine 206:2, pages 197-205.
Crossref
Esra ERTAN YAZAR, Elif Yelda NIKSARLIOGLU, Burcu YIGITBAS & Mesut BAYRAKTAROGLU. (2022) How to Utilize CAT and mMRC Scores to Assess Symptom Status of Patients with COPD in Clinical Practice?. Medeniyet Medical Journal 37:2, pages 173-179.
Crossref
Krishna Sunkara, Meenu Mehta, Saurabh Satija, Daljeet Singh Dhanjal, Parvarish Sharma, Shakti D. Shukla, Madhur Shastri, Flavia C. Zacconi, Kamal Dua & Venkata Sita Rama Raju Allam. 2022. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases. Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases 1 24 .
Ridhima Wadhwa, Taru Aggarwal, Vamshikrishna Malyla, Nitesh Kumar, Gaurav Gupta, Dinesh Kumar Chellappan, Harish Dureja, Meenu Mehta, Saurabh Satija, Monica Gulati, Pawan Kumar Maurya, Trudi Collet, Philip Michael Hansbro & Kamal Dua. (2019) Identification of biomarkers and genetic approaches toward chronic obstructive pulmonary disease. Journal of Cellular Physiology 234:10, pages 16703-16723.
Crossref
Jhonatan Betancourt-Peña, Vicente Benavides-Córdoba, Juan Carlos Avila-Valencia & Hamilton Elias Rosero-Carvajal. (2019) Differences Between COPD Patients of a Pulmonary Rehabilitation Program According to the mMRC Dyspnea Scale. Current Respiratory Medicine Reviews 15:1, pages 32-38.
Crossref
Suzanne G. Bollmeier, Terry L. Seaton, Theresa R. Prosser, Yi-Ting Chou, Kristine Reckenberg, Beth Hahn, Richard H. Stanford & Riju Ray. (2019) Assessment of symptom burden and adherence to respiratory medications in individuals self-reporting a diagnosis of COPD within a community pharmacy setting. Journal of the American Pharmacists Association 59:4, pages 479-488.e1.
Crossref
Frances Early, Matthew Lettis, Sarah-Jane Winders & Jonathan Fuld. (2019) What matters to people with COPD: outputs from Working Together for Change. npj Primary Care Respiratory Medicine 29:1.
Crossref
Anna E. WallaceShuchita KailaValentina BayerAsif ShaikhMayura U. ShindeVincent J. WilleyMark B. NapierJoseph R. Singer. (2019) Health Care Resource Utilization and Exacerbation Rates in Patients with COPD Stratified by Disease Severity in a Commercially Insured Population. Journal of Managed Care & Specialty Pharmacy 25:2, pages 205-217.
Crossref
Henrik Svedsater, June Roberts, Chloe Patel, Jake Macey, Emma Hilton & Lisa Bradshaw. (2017) Life Impact and Treatment Preferences of Individuals with Asthma and Chronic Obstructive Pulmonary Disease: Results from Qualitative Interviews and Focus Groups. Advances in Therapy 34:6, pages 1466-1481.
Crossref
Maria Montes de Oca, María Victorina López Varela, María Eugenia Laucho-Contreras, Alejandro Casas, Eduardo Schiavi, Alejandra Rey & Alejandra Silva. (2017) Clasificación de los pacientes con enfermedad pulmonar obstructiva crónica según los sistemas de estadificación de la Asociación Latinoamericana de Tórax (ALAT) y la iniciativa global para la enfermedad pulmonar obstructiva crónica (GOLD). Archivos de Bronconeumología 53:3, pages 98-106.
Crossref
María Montes de Oca, María Victorina López Varela, María Eugenia Laucho-Contreras, Alejandro Casas, Eduardo Schiavi, Alejandra Rey & Alejandra Silva. (2017) Classification of COPD Patients According to ALAT and GOLD Staging Systems Using PUMA Study Data. Archivos de Bronconeumología (English Edition) 53:3, pages 98-106.
Crossref
Jia-Xi Feng, Yun Lin, Jian Lin, Su-Su He, Mei-Fang Chen, Xiao-Mai Wu & You-Zu Xu. (2017) Relationship between Fractional Exhaled Nitric Oxide Level and Efficacy of Inhaled Corticosteroid in Asthma-COPD Overlap Syndrome Patients with Different Disease Severity. Journal of Korean Medical Science 32:3, pages 439.
Crossref
Gautam Raju Mehta, Rafat Mohammed, Sarah Sarfraz, Tajwaar Khan, Khansa Ahmed, Mauricio Villareal, Dennis Martinez, Joy Iskander & Rachid Mohammed. (2016) Chronic obstructive pulmonary disease: A guide for the primary care physician. Disease-a-Month 62:6, pages 164-187.
Crossref
MeiLan K Han, Carlos H Martinez, David H Au, Jean Bourbeau, Cynthia M Boyd, Richard Branson, Gerard J Criner, Ravi Kalhan, Thomas J Kallstrom, Angela King, Jerry A Krishnan, Suzanne C Lareau, Todd A Lee, Kathleen Lindell, David M Mannino, Fernando J Martinez, Catherine Meldrum, Valerie G Press, Byron Thomashow, Laura Tycon, Jamie Lamson Sullivan, John Walsh, Kevin C Wilson, Jean Wright, Barbara Yawn, Patrick M Zueger, Surya P Bhatt & Mark T Dransfield. (2016) Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective. The Lancet Respiratory Medicine 4:6, pages 473-526.
Crossref